Literature DB >> 15087457

DNA damage induces p53-dependent BRCA1 nuclear export.

Zhihui Feng1, Lisa Kachnic, Junran Zhang, Simon N Powell, Fen Xia.   

Abstract

The tumor suppressor gene BRCA1 plays an important role in the response to DNA damage. BRCA1 function is regulated by a variety of mechanisms including transcriptional control, phosphorylation, and protein-protein interactions. Recent studies have shown that BRCA1 is a nuclear-cytoplasmic shuttle protein. Its subcellular localization is controlled by a nuclear localization signal-mediated nuclear import via the importin receptor pathway and a nuclear export signal-facilitated nuclear export through a CRM1-dependent pathway. Using the human breast cancer cell line, MCF7, the subcellular distribution of BRCA1 was assessed by immunohistochemical staining and Western blotting analyses of fractionated subcellullar extracts. Ionizing radiation stimulated BRCA1 nuclear export in a dose-dependent manner. This DNA damage-induced BRCA1 nuclear export utilized a CRM1-dependent mechanism and also required wild-type p53, whose function was abrogated by the E6 protein in MCF7 cells. In addition, the dependence on p53 was confirmed using a second cell type operating a tetracycline-inducible system. The effect of ionizing radiation on BRCA1 export was observed in every phase of the cell cycle, although BRCA1 localization did vary between the G(1), S, and G(2)/M phases. These results imply that, in addition to ATM-, ATR-, and Chk2-dependent phosphorylations, cytoplasmic relocalization of BRCA1 protein is a mechanism whereby BRCA1 function is regulated in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087457     DOI: 10.1074/jbc.M404137200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Authors:  Konstantin S Leskov; Shinako Araki; John-Paul Lavik; Jose A Gomez; Vivian Gama; Efstathios S Gonos; Ioannis P Trougakos; Shigemi Matsuyama; David A Boothman
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 2.  The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.

Authors:  Yaqin Tu; Cai Chen; Junru Pan; Junfa Xu; Zhi-Guang Zhou; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

3.  Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent.

Authors:  Steven T Sizemore; Rahman Mohammad; Gina M Sizemore; Somaira Nowsheen; Hao Yu; Michael C Ostrowski; Arnab Chakravarti; Fen Xia
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

Review 4.  Revisiting p53 for cancer-specific chemo- and radiotherapy: ten years after.

Authors:  Jason M Beckta; Syed Farhan Ahmad; Hu Yang; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

5.  Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.

Authors:  Irene Guendel; Lawrence Carpio; Caitlin Pedati; Arnold Schwartz; Christine Teal; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 6.  The intersection between DNA damage response and cell death pathways.

Authors:  S Nowsheen; E S Yang
Journal:  Exp Oncol       Date:  2012-10

7.  Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.

Authors:  Eddy S Yang; Somaira Nowsheen; Mohammad A Rahman; Rebecca S Cook; Fen Xia
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

8.  Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

Authors:  Eddy S Yang; Hong Wang; Guochun Jiang; Somaira Nowsheen; Allie Fu; Dennis E Hallahan; Fen Xia
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

9.  NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.

Authors:  Nadire Duru; Ramkishore Gernapudi; Yongshu Zhang; Yuan Yao; Pang-Kuo Lo; Benjamin Wolfson; Qun Zhou
Journal:  Cancer Lett       Date:  2015-08-20       Impact factor: 8.679

10.  Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.

Authors:  Liping Li; Hong Wang; Eddy S Yang; Carlos L Arteaga; Fen Xia
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.